<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00631046</url>
  </required_header>
  <id_info>
    <org_study_id>H-A-2007-0088</org_study_id>
    <secondary_id>D203</secondary_id>
    <nct_id>NCT00631046</nct_id>
  </id_info>
  <brief_title>Essential Fatty Acids During Complementary Feeding</brief_title>
  <acronym>EFiON</acronym>
  <official_title>The Importance of Increasing Intake of Essential Fatty Acids During Complementary Feeding on Infant Growth and Body Composition, Intestinal Health, Immune Function and Risk Markers for Later Metabolic Complications.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Axellus</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <brief_summary>
    <textblock>
      The objective of this intervention study is to examine the effect of n-3 LCPUFA on growth and
      body composition, intestinal health and microbiotic composition, immune function and risk
      markers for later diseases in 9-18 months old infants and toddlers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Growth</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Body composition</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Intestinal microbiota</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma lipid profile</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin - glucose</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Erythrocyte fatty acid composition</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Ex vivo cytokine production</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>IGF-1 and IGFBP-3</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Adipokines</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma CRP</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma IgE</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucagon</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metagenome analysis (investigating the enzymatic capacity of the intestines through prokaryotic DNA sequencing)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iron status (hemoglobin, ferritin)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>faecal calprotectin</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FADS1 and FADS2 genotypes</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergy status</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Obesity</condition>
  <condition>Growth</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Fish Oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>containing n-3 LCPUFA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sunflower oil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>containing n-6 PUFA</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish Oil</intervention_name>
    <description>Daily dosage of 5 ml of fish oils from 9 months +/- 2weeks to 18 months +/- 4 weeks of age</description>
    <arm_group_label>Fish Oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sunflower Oil</intervention_name>
    <description>Daily dosage of 5 ml of sunflower oil from 9 months +/- 2weeks to 18 months +/- 4 weeks of age</description>
    <arm_group_label>Sunflower oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton infants, 9 mo +/- 2 wk, born &gt;= 37 wk of gestation

          -  Birth weight &gt;=2500g, a 5-min Apgar score &gt;= 7, birth weight &gt;= 5th percentile for
             gestational age

        Exclusion Criteria:

          -  Chronic diseases expected to influence growth and dietary intake

          -  Use of medicine expected to influence growth and dietary intake

          -  Fish oil supplementation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Months</minimum_age>
    <maximum_age>19 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim F Michaelsen, Dr Med Sci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Human Nutrition, LIFE, Univ. of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Human Nutrition</name>
      <address>
        <city>Copenhagen</city>
        <state>Frederiksberg C</state>
        <zip>DK-1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2008</study_first_submitted>
  <study_first_submitted_qc>March 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2008</study_first_posted>
  <last_update_submitted>July 14, 2009</last_update_submitted>
  <last_update_submitted_qc>July 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kim Fleischer Michaelsen, Dr Med Sci</name_title>
    <organization>Dept. of Human Nutrition, Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark</organization>
  </responsible_party>
  <keyword>n-3 LCPUFA</keyword>
  <keyword>Fish oil</keyword>
  <keyword>essential fatty acids</keyword>
  <keyword>infant growth</keyword>
  <keyword>obesity</keyword>
  <keyword>Intestinal microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

